‘No room for bad actors’ warns Althea boss by Steve Jones September 16, 2021April 26, 2024 Althea chief executive Josh Fegan has delivered a withering assessment of some industry players as he […]
Products pass TGA tests with flying colours – but quality and compliance concerns remain by Rhys Cohen September 2, 2021April 26, 2024
D-Day approaches for New Zealand’s medicinal cannabis scheme by Martin Lane August 25, 2021April 26, 2024
Relief for CBD-only patients as study rules out risk of positive drug-driving test by Hannah Adler August 19, 2021April 26, 2024
A year of frustration but Cann Group vows to deliver for shareholders and consumers by Steve Jones August 12, 2021April 26, 2024
Labor’s last-minute intervention in Victoria’s cannabis inquiry only delays the inevitable by Rhys Cohen August 5, 2021April 26, 2024
From AFL to LGP: the journey into medicinal cannabis for Fleta Solomon by Steve Jones August 5, 2021April 26, 2024
